In this thread I’m going to commit the cardinal scientific sin of oversimplification to try and explain vaccine, neutralizing antibodies and protection from infection/sickness/hospitalization/death

The numbers used here are to explain a concept and aren’t necessarily to scale
1/
Let’s imagine the virus can be killed by bullets.

These bullets are neutralizing antibodies - antibodies that neutralize (kill) the virus.

A few bullets will prevent death/hospitalization, more bullets will prevent illness, a lot of bullets may even prevent infection.
2/
When you get vaccinated against COVID-19 you have a gun loaded with bullets to destroy the virus (SARS-CoV-2)
These bullets are neutralizing antibodies (nAbs = bullets)
Eg.
OG SARS-CoV-2🇨🇳 was neutralized with 2 bullets
B.1.1.7🇬🇧 needed 4 bullets
B.1.351🇿🇦 needed 16 bullets
3/
Different vaccines give a different number of bullets

Eg

Pfizer, Moderna, Novavax vaccine 20 bullets

Past infection, AZ/COVISHILED/COVAXIN 10 bullets

But remember just 4 bullets maybe enough

Vaccines also form immune memory so we can make more bullets quickly if infected

4/
2 doses of COVISHIELD/COVAXIN may give 10 bullets

But 1 dose may give just 5 bullets

If you get exposed to OG SARS-CoV-2 (needs 2 bullets), B.1.1.7 (needs 4 bullets), you’re probably fine. You have enough bullets!

5/
Along comes B.1.351 (needs 16 bullets)
If you have 20 bullets😎
If you have 10 bullets🤧🤒
No vaccine ☠️🪦
Any vaccine > no vaccine, but mRNA vaccines appear better

Even if you have 2 bullets but have immune memory, you can make new bullets - may get sick but mild infection

6/
Along comes B.1.617.2🇮🇳
14 bullets😎=may never get infected or maybe just asymptomatic infection
6 bullets🤧🤒=may get mild infection
2 bullets🥵😭🫁may get moderately sick but you make new bullets quickly, so vaccine prevents death
No vaccine =no bullets= 🏥☠️🪦

7/
1 dose of vaccine may not give enough bullets (nAbs) to prevent mild infection but the vaccine may still protect from death!

The question is how many bullets does it take to prevent infection?

How many to prevent hospitalization/death?

How many bullets does B.1.617.2 need?

8/
Note : B.1.617.2 is a SARS-CoV-2 variant of concern that belongs to the lineage Indian scientists loving named “THE DOUBLE MUTANTZZZZZ” 🦠👻😱

According to new information form the UK, this variant of concern is more transmissible and has some degree of immune evasion.

9/
Good news is our existing vaccines are likely to continue to offer high protection from death.
Protection from hospitalization may decrease a little bit, don’t know yet.
Protection from symptomatic infection has decreased a lot for 1 dose & a little for 2 doses as well.
10/

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Dr. Swapneil Parikh

Dr. Swapneil Parikh Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @swapneilparikh

13 May
Provided COVAXIN single dose efficacy is >70%, models support delaying COVAXIN 2nd dose except for 65 years +
We should have had quality Ph3 data and real world data on COVAXIN by now. Unbelievable that we’re still doing guess work.
🧵
1/
Modeling study helps us understand lives saved with delayed second dose of Covaxin.

Assuming vaccination rate of 0.3% of population / day. The total cumulative mortality on day 180 is seen to be lower as below depending on efficacy. Makes sense if efficacy >70%
2/
Delayed second dose except for 65+ allows us to save lives but reduces the risk due to uncertain efficacy. Bottom line if COVAXIN single dose efficacy is >70% this approach makes sense given India’s daily vaccination rate. We’re unlikely to ever hit 1% population / day
3/
Read 9 tweets
12 May
Here’s a plan to get India 10-20% extra COVISHIELD vaccines doses overnight!

How could this be possible? Read on to find out.

🧵 1/

Antibody Responses After a Single Dose of ChAdOx1 nCoV-19 Vaccine in HCWs Previously Infected with SARS-CoV-2 medrxiv.org/content/10.110…
A study found that HCWs who had recovered from COVID-19 up-to 11 months prior responded incredibly to a single dose of AstraZeneca vaccine (COVISHIELD).
They had neutralizing antibodies against wild type virus but also neutralized P.1 & B.1.351 (immune escape variants)!
2/
In fact those who had COVID-19 in the past and took a single dose of AZ (COVISHIELD) had higher neutralizing antibodies than those who took 2 doses of Pfizer mRNA vaccine! That’s right - past infection plus 1 dose AZ higher nAbs than 2 doses of Pfizer!
3/

medrxiv.org/content/10.110…
Read 14 tweets
30 Jan
If we have to wait till June for COVOVAX, Indian regulators should hang their heads in shame.
They gave COVAXIN an EUA without any efficacy data or Ph3. Novavax has efficacy data from Ph3 in U.K. and Ph2 in SA. Ph3 in USA and Mexico underway. 1/
Indian regulators literally rewrote the rules for COVAXIN citing hypothetical superior efficacy against variants. What a load of BS (BOGUS science). They made up the restricted EUA in clinical trial mode BS. But a vaccine with 85%+ efficacy in Ph3 against B.1.1.7 is too risky! 2/
Is COVISHIELD good? Yes. But there’s a lack of data for >55 years. That’s more an issue with the trial than the vaccine. Is COVAXIN good? I don’t know, no publicly available Ph3 data. COVOVAX has AMAZING immunogenicity & reported AMAZING efficacy (need 2 wait for the preprint) 3/
Read 4 tweets
29 Jan
Let me just try to preempt all the BS (bad science) we will hear about hypothetical superiority of COVAXIN against variants vs Novavax. A thread 🧵 1/
Novavax is proven efficacious against OG COVID-19 and B.1.1.7 in a Phase 3 clinical trial in U.K. We should soon have the data in a preprint / peer reviewed publication. The confidence in the results will increase as more cases occur. 2/
Novavax has a Phase 2 trial in South Africa with an efficacy endpoint. That trial reported efficacy albeit reduced against B.1.351. The number of participants in the study was small, number of cases were low and therefore confidence in these results in lower than we need. 3/
Read 14 tweets
30 Jul 20
Mumbai’s sero-prevelance study - detailed report with technical details : tcs.tifr.res.in/~sandeepj/avai… @CT_Bergstrom @mlipsitch @cmyeaton @nataliexdean @apoorva_nyc @velumania 1/
2/Study period: 14 days in July 20.
Areas selected:Three wards (R-North, M-West and F-North) in Mumbai were chosen based on: (a) City and Suburban areas (b) East, West and North areas and (c) representative of areas with low to high prevalence based on reported cases on 02/06/20
3/Sampling design: Sampling from households in impoverished tenements or buildings, which were separated by at least 3 households/buildings ensured geographically separate and a systematic method for non-overlapping area coverage.
Read 14 tweets
17 Jun 20
Those of us following #RECOVERYtrial know it’s one of the most important clinical trials for COVID-19, not just for its potential to identify new therapeutic options but also to temper the excitement over unproven therapies. 1/
My thoughts on the RECOVERY trial PRESS release on mortality benefit for COVID-19 with dexamethasone.
RECOVERY trial is a large randomized controlled trial with multiple arms. 11k+ patients and multiple treatments being evaluated. See image for therapeutics under evaluation. 2/
First, what is dexamethasone?
Dexamethasone is a corticosteroid, commonly called a steroid (not the anabolic kind). In addition to many other effects, it can reduce the inflammatory resonse caused by an out of control immune system. 3/
Read 16 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(